Moreover, studies demonstrate that impaired NET degradation in severe COVID-19 establishes a vicious cycle of NETosis and ACPA production, perpetuating a pro-inflammatory milieu in seropositive RA patients (85). The gene discussed is PRTN3; the disease is rheumatoid arthritis.